Title 42 — The Public Health and Welfare
Part B · Chapter 6A — Public Health Service
§ 284o. Activities of the National Institutes of Health with respect to research on paralysis
Statutory text
Coordination
The Director of the National Institutes of Health (referred to in this section and sections 280g–9 and 284p of this title as the “Director”), pursuant to the general authority of the Director, may develop mechanisms to coordinate the paralysis research and rehabilitation activities of the Institutes and Centers of the National Institutes of Health in order to further advance such activities and avoid duplication of activities.
Christopher and Dana Reeve Paralysis Research Consortia
In general
The Director may make awards of grants to public or private entities to pay all or part of the cost of planning, establishing, improving, and providing basic operating support for consortia in paralysis research. The Director shall designate each consortium funded through such grants as a Christopher and Dana Reeve Paralysis Research Consortium.
Research
Each consortium under paragraph (1)—
may conduct basic, translational, and clinical paralysis research;
may focus on advancing treatments and developing therapies in paralysis research;
may focus on one or more forms of paralysis that result from central nervous system trauma or stroke;
may facilitate and enhance the dissemination of clinical and scientific findings; and
may replicate the findings of consortia members or other researchers for scientific and translational purposes.
Coordination of consortia; reports
The Director may, as appropriate, provide for the coordination of information among consortia under paragraph (1) and ensure regular communication among members of the consortia, and may require the periodic preparation of reports on the activities of the consortia and the submission of the reports to the Director.
Organization of consortia
Each consortium under paragraph (1) may use the facilities of a single lead institution, or be formed from several cooperating institutions, meeting such requirements as may be prescribed by the Director.
Public input
The Director may provide for a mechanism to educate and disseminate information on the existing and planned programs and research activities of the National Institutes of Health with respect to paralysis and through which the Director can receive comments from the public regarding such programs and activities.
Legislative history
Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.
Christopher and Dana Reeve Paralysis Act
Pub. L. 111–11 title XIV § 14101 · 123 Stat. 991
Enacted · 42 U.S.C. § 284o
(Pub. L. 111–11, title XIV, § 14101, Mar. 30, 2009, 123 Stat. 1452.)
Source evidence
Code source credit
(Pub. L. 111–11, title XIV, § 14101, Mar. 30, 2009, 123 Stat. 1452.)Enacted provision · exact public law section
SEC. 14101. ACTIVITIES OF THE NATIONAL INSTITUTES OF HEALTH WITH RESPECT TO RESEARCH ON PARALYSIS. (a) Coordination.— The Director of the National Institutes of Health (referred to in this title as the “Director”), pursuant to the general authority of the Director, may develop mechanisms to coordinate the paralysis research and rehabilitation activities of the Institutes and Centers of the National Institutes of Health in order to further advance such activities and avoid duplication of activities. (b) Christopher and Dana Reeve Paralysis Research Consortia.— (1) In general.— The Director may make awards of grants to public or private entities to pay all or part of the cost of planning, establishing, improving, and providing basic operating support for consortia in paralysis research. Designation. The Director shall designate each consortium funded through such grants as a Christopher and Dana Reeve Paralysis Research Consortium. (2) Research.— Each consortium under paragraph (1)— (A) may conduct basic, translational, and clinical paralysis research; (B) may focus on advancing treatments and developing therapies in paralysis research; (C) may focus on one or more forms of paralysis that result from central nervous system trauma or stroke; (D) may facilitate and enhance the dissemination of clinical and scientific findings; and (E) may replicate the findings of consortia members or other researchers for scientific and translational purposes. (3) Coordination of consortia; reports.— The Director may, as appropriate, provide for the coordination of information among consortia under paragraph (1) and ensure regular communication among members of the consortia, and may require the periodic preparation of reports on the activities of the consortia and the submission of the reports to the Director. (4) Organization of consortia.— Each consortium under paragraph (1) may use the facilities of a single lead institution, or be formed from several cooperating institutions, meeting such requirements as may be prescribed by the Director. (c) Public Input.— The Director may provide for a mechanism to educate and disseminate information on the existing and planned programs and research activities of the National Institutes of Health with respect to paralysis and through which the Director can receive comments from the public regarding such programs and activities.
1 of 1 references resolved to an enrolled provision
Editorial Notes
Codification
Section was enacted as part of the Christopher and Dana Reeve Paralysis Act, and also as part of the Omnibus Public Land Management Act of 2009, and not as part of the Public Health Service Act which comprises this chapter.